Twitter Linkedin-in

Immuno Series US: Virtual

15 - 16 October 2020 | PDT (UTC-7)
Menu
Book Now
Immuno Series US
15 - 16 October 2020 | PDT (UTC-7)

Join over 450 leaders, experts and scientists to discuss strategies to harness the immune system for the development of innovative therapeutics

Download Agenda
Register

Featuring over 40 presentations, the event brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development

3rd Annual Advances in Immuno-Oncology USA Congress

The Congress includes...

Over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools

Over 40 presentations and case studies focussed on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical research

Last Year's Agenda at a Glance

15 October 2020 – Day One

  • Discovery of Immuno-Oncology Therapies: Checkpoint Inhibitors, Cell & Gene Therapies and Cancer Vaccines
  • Translational Immuno-Oncology

16 October 2020 – Day Two

  • Discovery of Immuno-Oncology Therapies: Antibodies, Oncolytic Viruses and the Microbiome
  • Preclinical and Clinical Development

This event is co-located with the virtual event 5th Annual Biomarkers & Precision Medicine USA Congress.
Attendees will have full access to both events.

Pre-Event Webinars

You don't have to wait until October to get involved - register for our complimentary live webinars here.
Presented by our expert speakers, these webinars will give you advance insight into topics that will be covered at the event.

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

The following were confirmed speakers for the 2019 series.

James Breitmeyer

James Breitmeyer

Oncternal Therapeutics

Nektar Executive Portraits

Loui Madakamutil

Nektar Therapeutics

Neal Goodwin

Neal Goodwin

Machavert Pharmaceuticals

Ruth Seelige

Ruth Seelige

Pfizer

Catherine Sabatos-Peyton

Catherine Sabatos-Peyton

Novartis

Ross Stewart

Ross Stewart

Pfizer

Delegate Rates

Virtual passes are available in Free & Full levels. Click the comparison chart to see what access is provided at each level.
Book Now
Free & Full Pass Comparison

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.

Live and On-Demand Presentations

Benefit from the insight of our expert speakers via pre-recorded presentations and interactive live presentations

Virtual Conference Venue

Our fully featured platform offers an immersive conference experience, delivering all the benefits of an in-person event

Digital Networking Opportunities

Connect directly with other registrants of event around the world through direct 1-2-1 chat, video chat and group discussion

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
"I liked the long networking events between the talks. Also, I liked how the networking breaks/meals were in the same area as the exhibit booths. I think that we definitely got more traffic to our booth because of this arrangement. Also, I liked the wide range of presentation topics."
Field Application ScientisUltivue
“The event was very well organized and had a very targeted audience.”
Director of OperationsHematogenix Laboratory Services
"It's a focused conference with two relevant themes, biomarker and IO. Right amount of presentation so easier to digest. Small but much easier to talk to people for scientific discussion. Speakers from both academia and industry represented a good breath of topics. I learned good deal on cell therapies.”
Principal Scientist Cancer Informatics AstraZeneca
"I liked the smaller, more intimate setting and the inclusion of vendor talks to describe their companies capabilities."
Senior ScientistREMD Biotherapeutics
"The vendors were really relevant to my work and the presentations were outstanding."
CEOIschemia Care
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
BIOM IMM US Carousel
Post Event Report
Event statistics, testimonials, feedback and 2020 early programme info
Imaginab Carousel
Webinar Recording
Ivan Plavec, Chief Business Officer at ImaginAB discusses 'How CD8 Imaging Is Useful To Pharma Regarding Drug Research & Clinical Decision Making'
BiomUS
Biomarkers US: Virtual
Join over 450 leaders at Biomarkers Series: Virtual, discussing key opportunities and challenges in biomarker research and precision medicine
Immuno Key Image Carousel
Immuno US 2021
Join over 250 leaders, experts and scientists to discuss strategies to harness the immune system for the development of innovative therapeutics
Ruth Seelige Carousel Img
Q&A
Ruth Seelige, Senior Scientist, Pfizer on Analysis Of The Tumour Microenvironment

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Virtual Events

In-Person Events

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Virtual Attendance of the event is available in Free* and Full packages

Feature

Free

Full

Access to 10-15 live presentations and discussions

Access to the online platform

2 Days

7 Days

Access to all on-demand content (70+ presentations)

Ability to download all content

Access to conference documentation

(workbook, poster displays, etc.)

*Free passes are only available to industry R&D or academia.